Medtronic (MDT)

I happily own stock in Medtronic (MDT -2.25%), one of the largest medical device makers in the world. Of late, the company is struggling through a rough patch that has Wall Street worried about the fu...

Medtronic delivered solid earnings, with standout growth in Cardiovascular, but overall performance remains mixed due to weaker Neuroscience and MedSurg segments. Elliott Management's activist involve...

The use of robotics in surgery is on the rise. The market was valued at $800 million in 2015, and has since risen to over $3 billion.

A clutch of post-earnings price target increases by analysts helped raise Medtronic's (MDT 3.59%) stock at a healthy rate on Wednesday. The sturdy medical device specialist's shares rose by almost 4% ...

On Tuesday, Medtronic Plc MDT reported second-quarter earnings and announced key board appointments after Elliott Investment Management became the company's largest shareholder.

Medtronic plc MDT posted better-than-expected earnings for the first quarter and announced key board appointments on Tuesday, naming John Groetelaars and Bill Jellison as independent directors, effect...

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Medtronic (MDT -3.12%) stock had declined 3.6% through 2:45 p.m. ET Tuesday despite beating forecasts for fiscal 2026 first-quarter earnings this morning.

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 1.5% on Tuesday.

Medtronic's NYSE: MDT FQ1 results and guidance update did not spark a rally in the share price. Still, they did affirm a robust outlook that includes accelerating business growth, improving profitabil...